CPC A23K 20/24 (2016.05) [A23K 10/00 (2016.05); A23K 50/40 (2016.05); G01N 33/84 (2013.01); G01N 2800/347 (2013.01)] | 15 Claims |
1. A method of diagnosing and treating an animal at risk for chronic kidney disease (CKD), wherein the method comprises:
a. obtaining a blood sample from the animal;
b. determining an amount of magnesium in the blood sample of the animal;
c. comparing the amount of magnesium to predetermined reference values; wherein the predetermined reference values are based on average magnesium levels in blood in a control population;
d. diagnosing the animal as being at risk for the CKD if the amount of magnesium is below a first predetermined value or above a second predetermined reference value; and
e. providing the animal with a treatment regimen if the amount of magnesium is below a first predetermined value or above a second predetermined reference value, wherein the treatment regimen comprises:
(i) at least one treatment regimen selected from the group consisting of administering a composition comprising an effective amount of magnesium or a salt thereof, reducing phosphate intake, reducing protein intake, administering polyunsaturated fatty acids, administering a phosphate binder therapy, administering potassium, reducing dietary sodium intake, and combinations thereof, or
(ii) at least one treatment regimen selected from the group consisting of a dietary therapy, hemodialysis, renal replacement therapy, withdrawal of kidney damaging compounds, kidney transplantation, delaying or avoiding kidney damaging procedures, modifying diuretic administration, and combinations thereof.
|